test Browse by Author Names Browse by Titles of Works Browse by Subjects of Works Browse by Issue Dates of Works
       

Advanced Search
Home   
 
Browse   
Communities
& Collections
  
Issue Date   
Author   
Title   
Subject   
 
Sign on to:   
Receive email
updates
  
My Account
authorized users
  
Edit Profile   
 
Help   
About T-Space   

T-Space at The University of Toronto Libraries >
University of Toronto at Scarborough >
Bioline International Legacy Collection >
Bioline International Legacy Collection >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1807/7430

Title: REVIEW - Chlamydia testing in infertility management
Authors: Jolande A. Land
Keywords: Chlamydia trachomatis, Chlamydia antibody testing, tubal pathology, infertility, cervical screening, uterine instrumentation
Issue Date: 31-Dec-2004
Publisher: Middle East Fertility Society
Citation: Middle East Fertility Society Journal (ISSN: 1110-5690) Vol 9 Num 2
Abstract: In the majority of women, chlamydia infections occur during adolescence, and remain asymptomatic. These unrecognized and untreated infections may increase the risk for tubal factor subfertility at a later age. Since the association between chlamydia IgG antibodies in serum and tubal pathology was noticed, chlamydia antibody testing (CAT) has been used in the fertility work-up as an inexpensive and non-invasive screening test for tubal factor subfertility. The predictive value of CAT is limited, however, and clinicians should be aware of factors known to affect the diagnostic accuracy of CAT (such as test and cut-off titre used, and definition of tubal factor subfertility). Women who undergo uterine instrumentation (e.g. hysterosalpingography and laparoscopy with hydrotubation) are considered at risk for pelvic infections. In subfertile women, the incidence of active chlamydia infections is low (1-2%). But since the presence of viable chlamydia micro-organisms in their upper genital tracts cannot be excluded, prophylactic antibiotics before uterine instrumentation should be considered in all subfertile women, instead of endocervical screening for C. trachomatis and treatment of positive cases only.
URI: http://hdl.handle.net/1807/7430
Other Identifiers: http://www.bioline.org.br/abstract?id=mf04017
Rights: Copyright 2004 - Middle East Fertility Society
Appears in Collections:Bioline International Legacy Collection

Files in This Item:

File Description SizeFormat
mf04017.pdf69.54 kBAdobe PDF
View/Open

Items in T-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

uoft